Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPA1 | P15085 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PPID | Q08752 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CRHBP | P24387 | 1/20 | 0.31 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5163506 | 1.00 | CPA1 (0.50) | CPA1ALDH1A1TP53SMN1; SMN2PPID | |
| SCHEMBL4311206 | 0.92 | CPA1 (0.54) | CPA1ALDH1A1TP53SMN1; SMN2PPID | |
| SCHEMBL18191192 | 0.92 | CPA1 (0.46) | CPA1ALDH1A1TP53SMN1; SMN2PPID | |
| SCHEMBL4311209 | 0.92 | CPA1 (0.54) | CPA1ALDH1A1TP53SMN1; SMN2PPID | |
| SCHEMBL18191197 | 0.92 | CPA1 (0.46) | CPA1ALDH1A1TP53SMN1; SMN2PPID | |
| SCHEMBL6855469 | 0.87 | CPA1 (0.50) | CPA1ALDH1A1PPIDNPC1MAPT | |
| SCHEMBL1116701 | 0.85 | CPA1 (0.47) | CPA1ALDH1A1SMN1; SMN2LMNACYP2C19 | |
| SCHEMBL14042757 | 0.85 | CPA1 (0.47) | CPA1ALDH1A1SMN1; SMN2LMNACYP2C19 | |
| SCHEMBL20659551 | 0.84 | CPA1 (0.38) | CPA1ALDH1A1MAPTLMNAHPGD | |
| SCHEMBL13567330 | 0.79 | CPA1 (0.52) | CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3154930-B1 | METHOD FOR THE PREPARATION OF BETA-SUBSTITUTED GAMMA-AMINO CARBOXYLIC ACIDS | SIEGFRIED LTD (CH) | 2018-04-18 | — | — | EP | disclosed |
| US-9745249-B2 | Method for the preparation of beta-substituted gamma-amino carboxylic acids | SIEGFRIED LTD. (CH) | 2017-08-29 | — | — | US | disclosed |
| US-9745249-B2 | Method for the preparation of beta-substituted gamma-amino carboxylic acids | SIEGFRIED LTD. (CH) | 2017-08-29 | — | — | US | disclosed |
| US-20170114003-A1 | METHOD FOR THE PREPARATION OF BETA-SUBSTITUTED GAMMA-AMINO CARBOXYLIC ACIDS | SIEGFRIED LTD. (CH) | 2017-04-27 | — | — | US | disclosed |
| US-20170114003-A1 | METHOD FOR THE PREPARATION OF BETA-SUBSTITUTED GAMMA-AMINO CARBOXYLIC ACIDS | SIEGFRIED LTD. (CH) | 2017-04-27 | — | — | US | disclosed |
| WO-2016173960-A1 | OPTIMIZED SYNTHESIS OF PREGABALIN AND 4-AMINOBUTANE ACID USING AN IMPROVED METHOD FOR PRODUCING CONJUGATED NITROALKENES | K.H.S. PHARMA HOLDING GMBH (DE) | 2016-11-03 | — | — | WO | disclosed |
| WO-2015189068-A1 | METHOD FOR THE PREPARATION OF BETA-SUBSTITUTED GAMMA-AMINO CARBOXYLIC ACIDS | SIEGFRIED LTD. (CH) | 2015-12-17 | — | — | WO | disclosed |
| US-8546112-B2 | Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester | SANDOZ AG (CH) | 2013-10-01 | — | — | US | disclosed |
| US-8546112-B2 | Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester | SANDOZ AG (CH) | 2013-10-01 | — | — | US | disclosed |
| EP-2294207-B1 | Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester | SANDOZ AG (CH) | 2012-09-26 | — | — | EP | disclosed |
| US-20120142949-A1 | PROCESS FOR PREPARING PREGABALIN | HELVETICA INDUSTRIES (P) LIMITED (IN) | 2012-06-07 | — | — | US | disclosed |
| US-20110245508-A1 | Processes For Making Pregabalin And Intermediates Therefor | THIJS LAMBERTUS | 2011-10-06 | — | — | US | disclosed |
| US-20110165636-A1 | PROCESS FOR THE STEREOSELECTIVE ENZYMATIC HYDROLYSIS OF 5-METHYL-3-NITROMETHYL-HEXANOIC ACID ESTER | SANDOZ AG (CH) | 2011-07-07 | — | — | US | disclosed |
| US-20110165636-A1 | PROCESS FOR THE STEREOSELECTIVE ENZYMATIC HYDROLYSIS OF 5-METHYL-3-NITROMETHYL-HEXANOIC ACID ESTER | SANDOZ AG (CH) | 2011-07-07 | — | — | US | disclosed |
| EP-2300416-A1 | PROCESSES FOR MAKING PREGABALIN AND INTERMEDIATES THEREFOR | Synthon B.V. (NL) | 2011-03-30 | — | — | EP | disclosed |
| CN-1839116-B | Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst | SUMITOMO CHEMICAL CO | 2010-05-26 | — | — | CN | disclosed |
| US-20090312560-A1 | PROCESSES FOR MAKING PREGABALIN AND INTERMEDIATES THEREFOR | SYNTHON BV (NL) | 2009-12-17 | — | — | US | disclosed |
| WO-2009149928-A1 | PROCESSES FOR MAKING PREGABALIN AND INTERMEDIATES THEREFOR | SYNTHON B.V. (NL) | 2009-12-17 | — | — | WO | disclosed |
| WO-2009141362-A2 | PROCESS FOR THE STEREOSELECTIVE ENZYMATIC HYDROLYSIS OF 5-METHYL-3-NITROMETHYL-HEXANOIC ACID ESTER | SANDOZ AG (CH) | 2009-11-26 | — | — | WO | disclosed |
| CN-1839116-A | Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst | SUMITOMO CHEMICAL CO (JP) | 2006-09-27 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142949-A1 | PROCESS FOR PREPARING PREGABALIN | GRHPR, GABRG2, GABRG1 | CPA1 2405/4885ALDH1A1 214/4885TP53 4881/4885 |
| US-20170114003-A1 | METHOD FOR THE PREPARATION OF BETA-SUBSTITUTED GAMMA-AMINO CARBOXYLIC ACIDS | GLUL, GABRB2, GABRB1 | CPA1 2759/4885ALDH1A1 513/4885TP53 4142/4885 |
| US-20110245508-A1 | Processes For Making Pregabalin And Intermediates Therefor | GABRB2, GABRB1, GABRB3 | CPA1 3552/4885ALDH1A1 510/4885TP53 4796/4885 |
| US-20090312560-A1 | PROCESSES FOR MAKING PREGABALIN AND INTERMEDIATES THEREFOR | GABRB2, GABRB1, GABRB3 | CPA1 3552/4885ALDH1A1 510/4885TP53 4796/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.